BiotechTube

Neorecormon

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Anaemia

Conditions

Anaemia, Renal Transplantation, Kidney Failure

Trial Timeline

Apr 1, 2004 → May 1, 2010

NCT ID
NCT00396435

About Neorecormon

Neorecormon is a approved stage product being developed by Roche for Anaemia. The current trial status is completed. This product is registered under clinical trial identifier NCT00396435. Target conditions include Anaemia, Renal Transplantation, Kidney Failure.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00396435ApprovedCompleted

Competing Products

11 competing products in Anaemia

See all competitors
ProductCompanyStageHype Score
DS-1093 + placeboDaiichi SankyoPhase 1
33
Hetrombopag Olamine TabletJiangsu Hengrui MedicinePhase 1
33
Hetrombopag Olamine Tablet；Ciclosporin Soft CapsuleJiangsu Hengrui MedicinePhase 1
33
Hetrombopag Olamine TabletJiangsu Hengrui MedicinePhase 1
33
SAR445088SanofiPhase 1
32
BIVV020SanofiPhase 1
32
G-CSF + Early retreatment with ATGSanofiPhase 3
76
rilzabrutinib + placeboSanofiPhase 3
76
Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Lek d.d., Slovenia) + MALTOFER® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Vifor S.A., Switzerland)Sandoz GroupPhase 3
74
Ferric MaltolMedpacePhase 1
30
IV trivalent saccharose hydroxide ferrous + Oral ferrous fumarate + Oral and intravenous PlaceboRafael HoldingsApproved
77

Other Products from Roche

EmicizumabApproved
85
rituximab + methotrexate + methylprednisolone + acetaminophen + antihistamineApproved
85
RituximabApproved
85
mycophenolate mofetil [CellCept]Approved
85
saquinavir/ritonavir + atazanavir/ritonavirApproved
85